# Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

> **NCT02784054** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Intracranial Non-germinomatous Germ Cell Tumor

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide
- **DRUG:** Bleomycin
- **DRUG:** Thiotepa
- **DRUG:** Melphalan
- **RADIATION:** Reduced dose radiotherapy

## Key facts

- **NCT ID:** NCT02784054
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2021-03
- **Final completion:** 2023-03
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784054, "Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02784054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*